CY1110972T1 - Ανοσοκαταστολη με σαπερονινη 10 - Google Patents

Ανοσοκαταστολη με σαπερονινη 10

Info

Publication number
CY1110972T1
CY1110972T1 CY20101101115T CY101101115T CY1110972T1 CY 1110972 T1 CY1110972 T1 CY 1110972T1 CY 20101101115 T CY20101101115 T CY 20101101115T CY 101101115 T CY101101115 T CY 101101115T CY 1110972 T1 CY1110972 T1 CY 1110972T1
Authority
CY
Cyprus
Prior art keywords
donor
recipient animal
saperonin
immune
cpn10
Prior art date
Application number
CY20101101115T
Other languages
English (en)
Inventor
Geoffrey R Hill
Tatjana Banovic
Halle Morton
Alice Christina Cavanagh
Original Assignee
Cbio Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cbio Limited filed Critical Cbio Limited
Publication of CY1110972T1 publication Critical patent/CY1110972T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Η εφεύρεση κατευθύνεται προς την χρήση της cpn10 στην μεταμόσχευση και ιδιαίτερα στην αγωγή και/ή πρόληψη της νόσου του μοσχεύματος κατά του ξενιστή. Η εφεύρεση παρέχει μία μέθοδο χορήγησης cpn10 σε έναν δότη και/ή λήπτη ζώο ή κύτταρα, ιστούς ή όργανα που προέρχονται από τον δότη, όμως σε μια ιδιαιτέρως ωφέλιμη μορφή αγωγής και του δότη και του λήπτη ζώου. Η μέθοδος μπορεί επίσης να περιλαμβάνει την χορήγηση σε δότη και/ή λήπτη ζώο τουλάχιστον ενός άλλου ανοσοκατασταλτικού παράγοντα για να αποτραπεί ή να αμβλυνθεί η νόσος του μοσχεύματος κατά του ξενιστή.
CY20101101115T 2002-11-06 2010-12-03 Ανοσοκαταστολη με σαπερονινη 10 CY1110972T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2002952492A AU2002952492A0 (en) 2002-11-06 2002-11-06 Chaperonin 10 immunosuppression
EP03769073A EP1569679B1 (en) 2002-11-06 2003-11-06 Chaperonin 10 immunosuppression

Publications (1)

Publication Number Publication Date
CY1110972T1 true CY1110972T1 (el) 2015-06-11

Family

ID=28795882

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101101115T CY1110972T1 (el) 2002-11-06 2010-12-03 Ανοσοκαταστολη με σαπερονινη 10

Country Status (16)

Country Link
US (3) US7618935B2 (el)
EP (3) EP2818179A1 (el)
JP (2) JP4716731B2 (el)
KR (1) KR101088740B1 (el)
CN (1) CN100525832C (el)
AT (1) ATE489963T1 (el)
AU (1) AU2002952492A0 (el)
CA (1) CA2505141C (el)
CY (1) CY1110972T1 (el)
DE (1) DE60335202D1 (el)
DK (1) DK1569679T3 (el)
ES (1) ES2351993T3 (el)
NZ (1) NZ540433A (el)
PT (1) PT1569679E (el)
SI (1) SI1569679T1 (el)
WO (1) WO2004041300A1 (el)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060114011A (ko) * 2004-01-16 2006-11-03 씨바이오 리미티드 Ｔｏｌｌ-유사 수용체 유도성 사이토킨 및 케모킨 분비의샤페로닌 10 조절
AU2005204979B2 (en) * 2004-01-16 2010-10-21 Cbio Limited Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion
US8036710B2 (en) * 2004-05-07 2011-10-11 Qualcomm, Incorporated Power-efficient multi-antenna wireless device
AU2006269824B2 (en) * 2005-07-11 2012-04-19 Cbio Limited Chaperonin 10-induced immunomodulation
JP2009500430A (ja) 2005-07-11 2009-01-08 シーバイオ リミテッド シャペロニン１０により誘導される免疫調整方法
DK1937723T3 (en) 2005-08-31 2014-02-24 Invion Ltd Modified chaperonin 10
AU2006303826B2 (en) * 2005-10-20 2012-07-19 Cbio Limited Treatment of hypersensitivity
US20090087410A1 (en) * 2005-10-20 2009-04-02 Cbio Limited Treatment of hypersensitivity
BRPI0708503A2 (pt) 2006-03-02 2011-05-31 Cbio Ltd regulação das respostas imune por modulação da função do antìgeno presente em células
CN102015757B (zh) * 2008-04-11 2015-12-02 悉生物有限公司 修饰的Cpn10以及PRR信号
US20110243921A1 (en) * 2010-03-30 2011-10-06 Cbio Limited Prevention and treatment of cutaneous lupus erythematosus
WO2013158959A1 (en) * 2012-04-19 2013-10-24 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of graft-versus-host disease
US9688741B2 (en) 2012-10-23 2017-06-27 Elastagen Pty Ltd Elastic hydrogel
CA2933047A1 (en) 2012-12-10 2014-06-19 Elastagen Pty Ltd Scalable three-dimensional elastic construct manufacturing
WO2015021508A1 (en) 2013-08-13 2015-02-19 The University Of Sydney Regeneration of damaged tissue

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2176948C (en) * 1993-11-30 2007-05-15 Halle Morton Chaperonin 10
CA2177179C (en) * 1993-11-30 2006-10-17 Halle Morton Antagonists to chaperonin 10
US5989804A (en) * 1994-07-08 1999-11-23 New England Medical Center Hospitals, Inc. E6 binding proteins
EP0845994A1 (en) * 1995-08-09 1998-06-10 Schering Corporation Combined use of interleukin-10 and cyclosporin for immunosuppression therapy
US20020142000A1 (en) * 1999-01-15 2002-10-03 Digan Mary Ellen Anti-CD3 immunotoxins and therapeutic uses therefor
EP1218030A4 (en) * 1999-09-10 2004-09-15 Univ Fordham METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF GRAFT REJECTS USING THERMAL SHOCK PROTEINS
GB0028122D0 (en) * 2000-11-17 2001-01-03 St Georges Entpr Ltd Method

Also Published As

Publication number Publication date
DE60335202D1 (en) 2011-01-13
ES2351993T3 (es) 2011-02-14
KR20050086428A (ko) 2005-08-30
EP2255824B1 (en) 2014-07-23
EP1569679A4 (en) 2008-02-27
NZ540433A (en) 2008-03-28
CN100525832C (zh) 2009-08-12
EP1569679A1 (en) 2005-09-07
KR101088740B1 (ko) 2011-12-01
JP4716731B2 (ja) 2011-07-06
JP2006508099A (ja) 2006-03-09
PT1569679E (pt) 2010-12-14
US20060198834A1 (en) 2006-09-07
US20100099605A1 (en) 2010-04-22
CN1735428A (zh) 2006-02-15
CA2505141C (en) 2012-07-17
SI1569679T1 (sl) 2011-01-31
US20120082690A1 (en) 2012-04-05
EP2818179A1 (en) 2014-12-31
CA2505141A1 (en) 2004-05-21
US7618935B2 (en) 2009-11-17
ATE489963T1 (de) 2010-12-15
JP2011088920A (ja) 2011-05-06
US8067361B2 (en) 2011-11-29
DK1569679T3 (da) 2011-01-10
EP2255824A1 (en) 2010-12-01
AU2002952492A0 (en) 2002-11-21
WO2004041300A1 (en) 2004-05-21
EP1569679B1 (en) 2010-12-01

Similar Documents

Publication Publication Date Title
CY1110972T1 (el) Ανοσοκαταστολη με σαπερονινη 10
DK1487431T3 (da) Forebyggelse og/eller behandling af cardiovaskulær sygdom og/eller dermed associeret hjertefejl
ES2114888T3 (es) Tratamiento contra el rechazo en el transplante de organos.
CO5700767A2 (es) Procedimiento de tratamiento de rechazo de transplantes
ATE395418T1 (de) Alpha(1,3)galactosyltransferase-negatives schwein
ATE400577T1 (de) Anellierte dihydropyrane
EA200300738A1 (ru) Защита, восстановление и усиление эритропоэтинреактивных клеток, тканей и органов
DE60330468D1 (de) Schweine ohne jegliche expression funktioneller alpha-1,3-galactosyltransferase
ATE423577T1 (de) Biologisch modellierte implantierbare prothesen
IS7908A (is) Ný notkun dextransúlfats
EE9900470A (et) Tsinkhüaluronaadi kasutamine peptilise haavandi vastu
WO2005041877A3 (en) Method of inhibiting rejection following organ transplantation
DE69727948D1 (de) Sordarinderivate
TR200002847T2 (tr) Biçim VI 5, 6-dikloro-2-(izopropilamino) -1-(beta-L-ribofüranosil) -1H-benzimidazol.
FR2811229B1 (fr) Utilisation d'un polysaccharide excrete par l'espece vibrio diabolicus en cicatrisation osseuse
BG104259A (en) Derivatives of 4-cyano-4-deformylsordaricin
BG104258A (en) 4-cyano-4-deformylsordarin derivatives
NO20016326D0 (no) Anvendelse av proteinet UK 114 for å hindre avstötning av organtransplantatet
史梦 Even
of Man An act (Chapter No. 3) to prohibit commercial dealings in human organs intended for transplanting; to prohibit the transplanting of such organs between persons who are not genetically related; and for connected purposes. Dated 16 March 1993.(The Human Organ Transplants Act 1993)
Begley et al. World's First Mechanical Heart Implanted
史梦 Even" Healthy" Smokers Have Heart Disease
ATE253378T1 (de) Xenogene transplantation